S
ALBO

SignatureFD’s Albireo Pharma Inc ALBO Stock Holding History

SignatureFD’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-386
Closed -$8.34K – 3424
2022
Q4 		$8.34K Sell
386
-331
-46% -$7K ﹤0.01% 2238
2022
Q3 		$14K Buy
717
+659
+1,136% +$13.6K ﹤0.01% 1932
2022
Q2 		$1K Buy
+58
New +$1.53K ﹤0.01% 3063
2021
Q4 		– Sell
-33
Closed -$1K – 3338
2021
Q3 		$1K Hold
33
– – ﹤0.01% 2982
2021
Q2 		$1K Hold
33
– – ﹤0.01% 2901
2021
Q1 		$1K Hold
33
– – ﹤0.01% 2724
2020
Q4 		$1K Hold
33
– – ﹤0.01% 2515
2020
Q3 		$1K Hold
33
– – ﹤0.01% 2543
2020
Q2 		$1K Buy
+33
New +$778 ﹤0.01% 2437

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SignatureFD's ALBO Position: Q1 2023 in Review

SignatureFD sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 386 shares — an estimated $8.34K sold.

SignatureFD first reported a position in ALBO in Q2 2020 and held it in 9 quarters. The position peaked at $14K in Q3 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • SignatureFD reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • SignatureFD sold 386 Albireo Pharma Inc shares in Q1 2023, an estimated $8.34K.
  • SignatureFD first reported a position in Albireo Pharma Inc in Q2 2020 and held it in 9 quarters.
  • SignatureFD's Albireo Pharma Inc position peaked at $14K in Q3 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on SignatureFD's 13F filing for Q1 2023, filed 28 Apr 2023.